Integra LifeSciences Holdings Corp. (IART)
16.72
+0.28
(+1.70%)
USD |
NASDAQ |
Sep 04, 16:00
16.70
-0.02
(-0.15%)
After-Hours: 20:00
Integra LifeSciences Holdings Research and Development Expense (Quarterly) : 21.74M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.74M |
| March 31, 2026 | 18.69M |
| December 31, 2025 | 7.741M |
| September 30, 2025 | 20.42M |
| June 30, 2025 | 21.44M |
| March 31, 2025 | 21.22M |
| December 31, 2024 | 13.35M |
| September 30, 2024 | 26.30M |
| June 30, 2024 | 25.03M |
| March 31, 2024 | 21.20M |
| December 31, 2023 | 18.80M |
| September 30, 2023 | 22.24M |
| June 30, 2023 | 22.59M |
| March 31, 2023 | 19.21M |
| December 31, 2022 | 10.09M |
| September 30, 2022 | 19.56M |
| June 30, 2022 | 23.25M |
| March 31, 2022 | 18.75M |
| December 31, 2021 | 19.90M |
| September 30, 2021 | 20.16M |
| June 30, 2021 | 17.88M |
| March 31, 2021 | 16.58M |
| December 31, 2020 | 18.45M |
| September 30, 2020 | 18.60M |
| June 30, 2020 | 14.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.87M |
| December 31, 2019 | 12.38M |
| September 30, 2019 | 19.00M |
| June 30, 2019 | 17.63M |
| March 31, 2019 | 16.65M |
| December 31, 2018 | 20.30M |
| September 30, 2018 | 20.31M |
| June 30, 2018 | 19.11M |
| March 31, 2018 | 18.32M |
| December 31, 2017 | 17.18M |
| September 30, 2017 | 15.03M |
| June 30, 2017 | 15.75M |
| March 31, 2017 | 15.49M |
| December 31, 2016 | 13.90M |
| September 30, 2016 | 14.92M |
| June 30, 2016 | 14.68M |
| March 31, 2016 | 14.45M |
| December 31, 2015 | 13.29M |
| September 30, 2015 | 13.94M |
| June 30, 2015 | 13.89M |
| March 31, 2015 | 12.56M |
| December 31, 2014 | 12.16M |
| September 30, 2014 | 13.13M |
| June 30, 2014 | 13.24M |
| March 31, 2014 | 12.57M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 102.03M |
| Alphatec Holdings, Inc. | 18.17M |
| Boston Scientific Corp. | 554.00M |
| CONMED Corp. | 15.50M |
| Teleflex, Inc. | 45.12M |